Kim, Sun Kyung
Dickinson, Miles Sasha
Finer-Moore, Janet
Guan, Ziqiang http://orcid.org/0000-0002-8082-3423
Kaake, Robyn M. http://orcid.org/0000-0002-8341-3067
Echeverria, Ignacia
Chen, Jen
Pulido, Ernst H. http://orcid.org/0000-0002-3616-9743
Sali, Andrej http://orcid.org/0000-0003-0435-6197
Krogan, Nevan J. http://orcid.org/0000-0003-4902-337X
Rosenberg, Oren S. http://orcid.org/0000-0002-5736-4388
Stroud, Robert M. http://orcid.org/0000-0003-2083-5665
Article History
Received: 8 February 2022
Accepted: 21 December 2022
First Online: 13 February 2023
Competing interests
: The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche and Rezo Therapeutics. N.J.K. has financially compensated consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics, Interline Therapeutics, Rezo Therapeutics, GEn1E Lifesciences, Inc. and Twist Bioscience Corp. He is on the Board of Directors of Rezo Therapeutics and is a shareholder in Tenaya Therapeutics, Maze Therapeutics, Rezo Therapeutics and Interline Therapeutics.